Daily non-political popular news in brief.

Novel vaccine concept developed by scientists at the Wistar Institute

A new vaccine design strategy developed by scientists at the Wistar Institute could help to develop vaccines against diseases like AIDS and cervical cancer. The secret is using a herpes simplex protein called glycoprotein D to block a receptor molecule on antigen-presenting cells. Wistar scientists showed that vaccine vectors made by fusing glycoprotein D with genes from HIV and HPV antigens increase the immune system's response to those antigens in cell cultures and mice.

Read more »

Keywords: novel, vaccine, concept, developed, scientists, wistar, institute, scientist

« Previous | Next »

Similar news on "Novel vaccine concept developed by scientists at the Wistar Institute":

1. Virus used to create experimental HIV vaccines directly impairs the immune response
   11-15-2007 · EurekAlert!
   Leading efforts to create an HIV vaccine have hinged on the use of viruses as carriers for selected elements of the HIV virus. Recently, however, evidence has emerged that some of these so-called viral vector systems may undermine the immune system and should not be used for vaccine development. Now, a new study from scientists at the Wistar Institute provides strong support for the idea that some viral-vector vaccines may cause more harm than good.
   Similar news · Read more »
   
2. Novel regulatory mechanism identified for key tumor suppressor p53
   11-15-2006 · EurekAlert!
   Collaborating scientists from the Wistar Institute in Philadelphia and the Vienna Biocenter in Austria have identified a novel mechanism involved in normal repression of the p53 protein, perhaps the single most important molecule for the control of cancer in humans. The new molecular pathway described in the study suggests intriguing approaches to diagnosing or intervening in the progression of many types of cancer.
   Similar news · Read more »
   
3. Scientists discover novel way to remove iron from ferritin
   11-02-2007 · EurekAlert!
   A new study led by Children's Hospital Oakland Research Institute senior scientist, Elizabeth Theil, PhD, is the first to suggest that a small protein or heptapeptide could be used to accelerate the removal of iron from ferritin. The results of this study may help scientists develop new medications that dramatically improve the removal of excess iron in patients diagnosed with blood diseases such as B-Thalassemia (Cooley's anemia) or sickle cell disease.
   Similar news · Read more »
   
4. Scripps research scientists develop innovative dual action anthrax vaccine-antitoxin combination
   10-04-2007 · EurekAlert!
   Scientists at the Scripps Research Institute and the Salk Institute for Biological Studies have developed a new and highly effective agent that provides protection against anthrax by combining a fast-acting anthrax toxin inhibitor with a vaccine in a single compound.
   Similar news · Read more »
   
5. Harvard scientists partner to develop and distribute new tuberculosis vaccine
   02-17-2007 · EurekAlert!
   Bioengineers and public health researchers at Harvard University have developed a novel spraying method for delivering the most common tuberculosis (TB) vaccine, providing a new low-cost and scaleable technique that offers needle-free delivery and greater stability at room temperature than existing methods. The process could one day provide a better approach for vaccination against TB and help prevent the related spread of HIV/AIDS in the developing world.
   Similar news · Read more »
   
6. Scientists solve structure of gene regulator that plays key role in cancer
   02-13-2008 · EurekAlert!
   Scientists at the Wistar Institute have collaborated on a major advance in understanding a gene regulator that contributes to some of the deadliest cancers in humans. Their research paves the way for the development of new cancer therapies. The scientists have elucidated the 3-D structure of a key segment of p300/CBP, one of the most studied enzymes in the HAT family. Aberrant p300/CBP activity contributes to pancreatic, colon, and lung cancer and also can suppress tumors.
   Similar news · Read more »
   
7. Novel antigen-cloning technique may boost efforts to develop a melanoma vaccine
   04-15-2007 · EurekAlert!
   Experimental vaccines to help the immune system fight tumors have rarely been designed to directly stimulate helper T cells, one of the body's most critical immune responders, because of the difficult process required to isolate and clone antigens for vaccine development. Now, a new technique may allow scientists to create a melanoma vaccine able to stimulate helper T cells. The approach may also aid in the development of other vaccines against cancers or infectious diseases.
   Similar news · Read more »
   
8. Harvard team creates spray drying technique for TB vaccine
   02-12-2007 · EurekAlert!
   Bioengineers and public health researchers have developed a novel spray drying method for preserving and delivering the most common tuberculosis (TB) vaccine. The spray drying process could one day provide a better approach for vaccination against TB and help prevent the related spread of HIV/AIDS in the developing world.
   Similar news · Read more »
   
9. Staph vaccine shows promise in mouse study
   10-30-2006 · EurekAlert!
   By combining four proteins of Staphylococcus aureus that individually generated the strongest immune response in mice, scientists have created a vaccine that significantly protects the animals from diverse strains of the bacterium that cause disease in humans. A report describing the University of Chicago study, funded by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, appears online this week in the Proceedings of the National Academy of Sciences.
   Similar news · Read more »
   
10. Scientists sequence genome of parasite responsible for common sexually transmitted infection
    01-11-2007 · EurekAlert!
    Researchers have decoded the genetic makeup of the parasite that causes trichomoniasis, one of the most common sexually transmitted infections (STIs), revealing potential clues as to why the parasite has become increasingly drug resistant and suggesting possible pathways for new treatments, diagnostics and a potential vaccine strategy. The genome sequencing project, funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), is detailed in the January 12 issue of Science.
    Similar news · Read more »